HOME >> BIOLOGY >> NEWS
Hepatitis E virus infection may be widespread in rats

A study led by researchers at the National Institutes of Health (NIH) suggests that hepatitis E virus (HEV) is common among wild rats in the United States.

Although hepatitis E disease is very rare among people in the United States, many have HEV antibodies in their blood -- evidence that they were once infected with the virus, even though it did not make them sick. The finding raises questions about whether there is any connection between rats and HEV infection in humans. A report of the study appears in the August 1999 issue of the American Journal of Tropical Medicine and Hygiene.

Scientists analyzed blood samples from 239 rats captured in alleyways in Baltimore, MD, along the Mississippi River levee in New Orleans, LA, and in urban and rural areas of Hawaii. Tests revealed that more than 80 percent of the rats had HEV antibodies in their blood, evidence of prior HEV infection. Yamina Kabrane-Lazizi, Ph.D., of the National Institute of Allergy and Infectious Diseases (NIAID) was lead author of the study. Her collaborators included scientists from the National Institute of Neurological Disorders and Stroke, the Johns Hopkins School of Public Health in Baltimore, and the John A. Burns School of Medicine in Honolulu, HI.

Hepatitis E disease generally affects young adults and usually is not life-threatening, except in pregnant women infected with the virus where fatality rates of 15 to 20 percent have been reported. According to the Centers for Disease Control and Prevention (CDC), virtually all cases of hepatitis E disease in the United States have occurred among travelers returning from developing countries, where the disease is endemic and spread through contaminated drinking water. Nevertheless, tests show that between 1 and 5 percent of healthy blood donors in the United States have HEV antibodies in their blood.

"Since hepatitis E is so rare in this country, it's puzzling that so many people have antibodies to the virus in their bloo
'"/>

Contact: John Bowersox
jbowersox@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
19-Aug-1999


Page: 1 2 3

Related biology news :

1. Risk of Hepatitis E from consumption of deer?
2. Hepatitis C infection does not alter HIV progression or treatment
3. Need, potential for Hepatitis C vaccine highlighted by Hopkins study
4. Hepatitis E recovered from rats in Los Angeles
5. Hepatitis C drug overwhelms virus with flood of mutations - surprising mechanism may improve anti-viral treatments, UCSF study finds
6. Explaining the persistence of Hepatitis C
7. High percentage of Hepatitis C patients take herbs and vitamins, according to Rush survey
8. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
9. Hepatitis C is not a silent disease
10. Hepatitis Cs interferon resistance mechanism discovered
11. Immune Response To Hepatitis B Spares Liver Cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... -- BioCatch , the global leader in behavioral biometrics, ... grew to over 40 granted and pending patents. ... , , The Company,s IP ... System, Device, and Method Estimating Force Applied to a Touch Surface, ... costly hardware components needed to estimate the force and pressure applied to ...
(Date:12/6/2016)... , Dec. 6, 2016 Valencell , the ... it has seen a third consecutive year of triple ... technology in 2016 with a 360 percent increase in ... This increase was driven by sales of its wrist ... interest in its technology for hearables for fitness and ...
(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... ... December 07, 2016 , ... A new ... the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet ... population and timing of blood sampling may improve the value of a blood-based ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest ... development and commercialization of immunotherapeutic products for the ... entered into an Antibody Manufacturing Development Program with ... , USA) for its oregovomab antibody product. Supported ... Phase IIb clinical study in ovarian cancer patients, ...
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)... , Dec. 7, 2016  Genprex, Inc. ... revolutionary immunogene therapy treatments, today announced that it ... within a leading strategic communications and advisory firm, ... program. The program will combine investor relations, public ... of raising the profile of Genprex and its ...
Breaking Biology Technology:
Cached News: